WHO ICTRP trial
Comparison of optic nerve perfusion after pan retinal photocoagulation (PRP)…
PACTR202206535473146 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR202206535473146 |
|---|---|
| Public title | Comparison of optic nerve perfusion after pan retinal photocoagulation (PRP) versus anti vascular endothelial growth factor (antiVEGF) injection for treatment of high risk proliferative diabetic retinopathy(PDR) |
| Scientific title | Comparison of optic nerve perfusion after pan retinal photocoagulation (PRP) versus anti vascular endothelial growth factor (antiVEGF) injection for treatment of high risk proliferative diabetic retinopathy (PDR) |
| Primary sponsor | Ain shams university hospital |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Egypt |
| Conditions | Eye Diseases Paediatrics;Eye Diseases;Paediatrics |
| Interventions | intravitreal anti VEGF Ranizumab ;panretinal photocoagulation PRP |
| Registration date | May 26, 2022 |
| Target size | 50 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: